Tonix Pharmaceuticals Holding Corp. (TNXP)
3.01
-0.23
(-7.10%)
USD |
NASDAQ |
Nov 13, 16:00
3.06
+0.05
(+1.66%)
After-Hours: 19:59
Tonix Pharmaceuticals EPS Diluted (Quarterly) : -2.892 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.892 |
| June 30, 2026 | -2.438 |
| March 31, 2026 | -2.932 |
| December 31, 2025 | -3.976 |
| September 30, 2025 | -3.587 |
| June 30, 2025 | -3.858 |
| March 31, 2025 | -2.839 |
| December 31, 2024 | -976.70 |
| September 30, 2024 | -0.2288 |
| June 30, 2024 | -19.28 |
| March 31, 2024 | -0.1847 |
| December 31, 2023 | -0.8603 |
| September 30, 2023 | -1.825 |
| June 30, 2023 | -2.678 |
| March 31, 2023 | -3.256 |
| December 31, 2022 | -3.471 |
| September 30, 2022 | -4.318 |
| June 30, 2022 | -7.642 |
| March 31, 2022 | -10.12 |
| December 31, 2021 | -13.10 |
| September 30, 2021 | -10.11 |
| June 30, 2021 | -14.22 |
| March 31, 2021 | -14.24 |
| December 31, 2020 | -16.52 |
| September 30, 2020 | -18.85 |
| Date | Value |
|---|---|
| June 30, 2020 | -45.45 |
| March 31, 2020 | -74.78 |
| December 31, 2019 | -571.51 |
| September 30, 2019 | -1137.70 |
| June 30, 2019 | -1893.94 |
| March 31, 2019 | -2571.26 |
| December 31, 2018 | -6675.34 |
| September 30, 2018 | -11430.00 |
| June 30, 2018 | -14600.00 |
| March 31, 2018 | -17600.00 |
| December 31, 2017 | -14200.00 |
| September 30, 2017 | -15400.00 |
| June 30, 2017 | -41.60M |
| March 31, 2017 | -25400.00 |
| December 31, 2016 | -40000.00 |
| September 30, 2016 | -58000.00 |
| June 30, 2016 | -100000.0 |
| March 31, 2016 | -148000.0 |
| December 31, 2015 | -142000.0 |
| September 30, 2015 | -144000.0 |
| June 30, 2015 | -146000.0 |
| March 31, 2015 | -142000.0 |
| December 31, 2014 | -166000.0 |
| September 30, 2014 | -142000.0 |
| June 30, 2014 | -122000.0 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -0.0262 |
| Inovio Pharmaceuticals, Inc. | -0.4989 |
| Nektar Therapeutics | -1.229 |
| Karyopharm Therapeutics, Inc. | -2.316 |
| Minerva Neurosciences, Inc. | -0.1852 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.33M |
| Revenue (Quarterly) | 17.23M |
| Total Expenses (Quarterly) | 70.56M |
| Enterprise Value | -99.49M |
| Gross Profit Margin (Quarterly) | 89.00% |
| Profit Margin (Quarterly) | -309.4% |
| Earnings Yield | -406.6% |
| Normalized Earnings Yield | -406.57 |